Skip to content
Sodium chromate cr 51
Sodium chromate cr 51 is a small molecule pharmaceutical. Sodium chromate cr 51 was first approved as Sodium chromate cr 51 on 1982-01-01.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Sodium chromate cr-51
Tradename
Company
Number
Date
Products
SODIUM CHROMATE CR 51CuriumN-016708 DISCN1982-01-01
1 products
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
1 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Glucosephosphate dehydrogenase deficiencyD005955EFO_0007287————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameSODIUM CHROMATE CR 51
INNsodium chromate (51cr)
Description
Sodium chromate cr 51 is a small molecule pharmaceutical. Sodium chromate cr 51 was first approved as Sodium chromate cr 51 on 1982-01-01.
Classification
Small molecule
Drug class—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID10039-53-9
RxCUI—
ChEMBL IDCHEMBL2096634
ChEBI ID—
PubChem CID—
DrugBank—
UNII IDXI776WYU0N (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 131 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details